FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

412328000: Azacitidine (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2004. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
2467780013 Azacitidine (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
2473913010 Azacitidine en Synonym Active Entire term case insensitive SNOMED CT core module
2478313015 Ladakamycin en Synonym Active Entire term case insensitive SNOMED CT core module
2478315010 Azacytidine en Synonym Active Entire term case insensitive SNOMED CT core module
3721864011 5 azacytidine en Synonym Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Azacitidine Is a Pyrimidine false Inferred relationship Existential restriction modifier
Azacitidine Is a Pyrimidine analog true Inferred relationship Existential restriction modifier
Azacitidine Has disposition Antimetabolite true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing azacitidine Has active ingredient True Azacitidine Inferred relationship Existential restriction modifier 1
Azacitidine 100mg powder for injection vial Has active ingredient False Azacitidine Inferred relationship Existential restriction modifier
Azacitidine Has active ingredient True Azacitidine Inferred relationship Existential restriction modifier 1
Product containing azacitidine in oral dose form (medicinal product form) Has active ingredient True Azacitidine Inferred relationship Existential restriction modifier 1
Product containing only azacitidine in oral dose form (medicinal product form) Has active ingredient True Azacitidine Inferred relationship Existential restriction modifier 1
Product containing only azacitidine in parenteral dose form (medicinal product form) Has active ingredient True Azacitidine Inferred relationship Existential restriction modifier 1
Product containing azacitidine in parenteral dose form (medicinal product form) Has active ingredient True Azacitidine Inferred relationship Existential restriction modifier 1
Product containing precisely azacitidine 100 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Has basis of strength substance False Azacitidine Inferred relationship Existential restriction modifier 1
Product containing precisely azacitidine 100 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Has precise active ingredient False Azacitidine Inferred relationship Existential restriction modifier 1
Product containing precisely azacitidine 200 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance True Azacitidine Inferred relationship Existential restriction modifier 1
Product containing precisely azacitidine 200 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Azacitidine Inferred relationship Existential restriction modifier 1
Product containing precisely azacitidine 300 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance True Azacitidine Inferred relationship Existential restriction modifier 1
Product containing precisely azacitidine 300 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Azacitidine Inferred relationship Existential restriction modifier 1
Product containing precisely azacitidine 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has precise active ingredient True Azacitidine Inferred relationship Existential restriction modifier 1
Product containing precisely azacitidine 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has basis of strength substance True Azacitidine Inferred relationship Existential restriction modifier 1
Product containing precisely azacitidine 100 milligram/1 vial powder for conventional release suspension for injection (clinical drug) Has precise active ingredient True Azacitidine Inferred relationship Existential restriction modifier 1
Product containing precisely azacitidine 100 milligram/1 vial powder for conventional release suspension for injection (clinical drug) Has basis of strength substance True Azacitidine Inferred relationship Existential restriction modifier 1
Azacitidine 200mg tablets Has specific active ingredient True Azacitidine Inferred relationship Existential restriction modifier
Azacitidine 300mg tablets Has specific active ingredient True Azacitidine Inferred relationship Existential restriction modifier
Azacitidine 100mg powder for suspension for injection vials (Accord Healthcare Ltd) Has specific active ingredient True Azacitidine Inferred relationship Existential restriction modifier
Azacitidine 100mg powder for suspension for injection vials (Accord Healthcare Ltd) 1 vial Has specific active ingredient True Azacitidine Inferred relationship Existential restriction modifier
Azacitidine 150mg powder for suspension for injection vials Has specific active ingredient True Azacitidine Inferred relationship Existential restriction modifier
Azacitidine 150mg powder for suspension for injection vials (Accord Healthcare Ltd) Has specific active ingredient True Azacitidine Inferred relationship Existential restriction modifier
Onureg 300mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) Has specific active ingredient True Azacitidine Inferred relationship Existential restriction modifier
Onureg 300mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) 7 tablet Has specific active ingredient True Azacitidine Inferred relationship Existential restriction modifier
Azacitidine 150mg powder for suspension for injection vials 1 vial Has specific active ingredient True Azacitidine Inferred relationship Existential restriction modifier
Onureg 200mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) Has specific active ingredient True Azacitidine Inferred relationship Existential restriction modifier
Azacitidine 150mg powder for suspension for injection vials (Accord Healthcare Ltd) 1 vial Has specific active ingredient True Azacitidine Inferred relationship Existential restriction modifier
Onureg 200mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) 7 tablet Has specific active ingredient True Azacitidine Inferred relationship Existential restriction modifier
Azacitidine 300mg tablets 7 tablet Has specific active ingredient True Azacitidine Inferred relationship Existential restriction modifier
Azacitidine 200mg tablets 7 tablet Has specific active ingredient True Azacitidine Inferred relationship Existential restriction modifier
Azacitidine 100mg powder for suspension for injection vials (Kent Pharma (UK) Ltd) Has specific active ingredient True Azacitidine Inferred relationship Existential restriction modifier
Azacitidine 100mg powder for suspension for injection vials (Kent Pharma (UK) Ltd) 1 vial Has specific active ingredient True Azacitidine Inferred relationship Existential restriction modifier
Azacitidine 100mg powder for suspension for injection vials (Dr Reddy's Laboratories (UK) Ltd) Has specific active ingredient True Azacitidine Inferred relationship Existential restriction modifier
Azacitidine 100mg powder for suspension for injection vials (Dr Reddy's Laboratories (UK) Ltd) 1 vial Has specific active ingredient True Azacitidine Inferred relationship Existential restriction modifier
Azacitidine 100mg powder for suspension for injection vials (Tillomed Laboratories Ltd) 1 vial Has specific active ingredient True Azacitidine Inferred relationship Existential restriction modifier
Azacitidine 100mg powder for suspension for injection vials (Tillomed Laboratories Ltd) Has specific active ingredient True Azacitidine Inferred relationship Existential restriction modifier
Azacitidine 100mg powder for suspension for injection vials (Sandoz Ltd) Has specific active ingredient True Azacitidine Inferred relationship Existential restriction modifier
Azacitidine 100mg powder for suspension for injection vials (Sandoz Ltd) 1 vial Has specific active ingredient True Azacitidine Inferred relationship Existential restriction modifier
Azacitidine 100mg powder for suspension for injection vials (Seacross Pharmaceuticals Ltd) 1 vial Has specific active ingredient True Azacitidine Inferred relationship Existential restriction modifier
Azacitidine 100mg powder for suspension for injection vials (Seacross Pharmaceuticals Ltd) Has specific active ingredient True Azacitidine Inferred relationship Existential restriction modifier
Azacitidine 100mg powder for suspension for injection vials (Zentiva Pharma UK Ltd) 1 vial Has specific active ingredient True Azacitidine Inferred relationship Existential restriction modifier
Azacitidine 100mg powder for suspension for injection vials (Zentiva Pharma UK Ltd) Has specific active ingredient True Azacitidine Inferred relationship Existential restriction modifier
Azacitidine 100mg powder for suspension for injection vials (Viatris UK Healthcare Ltd) 1 vial Has specific active ingredient True Azacitidine Inferred relationship Existential restriction modifier
Azacitidine 100mg powder for suspension for injection vials (Viatris UK Healthcare Ltd) Has specific active ingredient True Azacitidine Inferred relationship Existential restriction modifier
Azacitidine 100mg powder for suspension for injection vials Has active ingredient False Azacitidine Inferred relationship Existential restriction modifier
Vidaza 100mg powder for suspension for injection vials (Bristol-Myers Squibb Pharmaceuticals Ltd) Has active ingredient True Azacitidine Inferred relationship Existential restriction modifier
Azacitidine 100mg powder for suspension for injection vials Has specific active ingredient True Azacitidine Inferred relationship Existential restriction modifier
Vidaza 100mg powder for suspension for injection vials (Bristol-Myers Squibb Pharmaceuticals Ltd) Has specific active ingredient True Azacitidine Inferred relationship Existential restriction modifier
Vidaza 100mg powder for suspension for injection vials (Bristol-Myers Squibb Pharmaceuticals Ltd) 1 vial Has specific active ingredient True Azacitidine Inferred relationship Existential restriction modifier
Azacitidine 100mg powder for suspension for injection vials 1 vial Has specific active ingredient True Azacitidine Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start